Search Results - "Bunce, Chris"
-
1
A quick, simple and unbiased method to quantify C2C12 myogenic differentiation
Published in Muscle & nerve (01-09-2011)“…Introduction: C2C12 myoblasts undergo in vitro myogenesis to form protein‐rich multinucleated myotubes. Determining the fraction of total nuclei incorporated…”
Get full text
Journal Article -
2
The ‘known-knowns', and ‘known-unknowns' of extracellular Nm23-H1/NDPK proteins
Published in Laboratory investigation (01-05-2018)“…Nucleoside diphosphate kinases (NDPKs/NDK/NME) are a multifunctional class of proteins conserved throughout evolution. Whilst many of the functions of NDPKs…”
Get full text
Journal Article -
3
Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies
Published in Blood cancer journal (New York) (07-10-2022)“…Despite enormous global investment, translational medical research faces considerable challenges and patients, and their doctors are frequently frustrated by…”
Get full text
Journal Article -
4
Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids
Published in Cancer research (Chicago, Ill.) (15-06-2015)“…The redeployed drug combination of bezafibrate and medroxyprogesterone acetate (designated BaP) has potent in vivo anticancer activity in acute myelogenous…”
Get full text
Journal Article -
5
Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing
Published in British journal of cancer (01-02-2022)“…Background We previously demonstrated the in vitro killing of AML cells by the combination of the lipid-lowering agent bezafibrate (BEZ) and the contraceptive…”
Get full text
Journal Article -
6
Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers
Published in Molecular cancer (14-12-2009)“…Over recent years, enzymes of the aldo-keto reductase (AKR) 1C subfamily have been implicated in the progression of prostate, breast, endometrial and leukemic…”
Get full text
Journal Article -
7
Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia
Published in PloS one (07-12-2009)“…The majority of acute myeloid leukaemia (AML) patients are over sixty years of age. With current treatment regimens, survival rates amongst these, and also…”
Get full text
Journal Article -
8
Active multiple myeloma suppresses and typically eliminates coexisting MGUS
Published in British journal of cancer (05-09-2017)“…Background: Myeloma is consistently preceded by premalignant monoclonal gammopathy of undetermined significance (MGUS). In >5% of MGUS patients there is a…”
Get full text
Journal Article -
9
AKR1C Isoforms Represent a Novel Cellular Target for Jasmonates alongside Their Mitochondrial-Mediated Effects
Published in Cancer research (Chicago, Ill.) (01-06-2009)“…Members of the aldo-keto reductase (AKR) superfamily, particularly the AKR1C subfamily, are emerging as important mediators of the pathology of cancer. Agents…”
Get full text
Journal Article -
10
Prostaglandin D2 inhibits C2C12 myogenesis
Published in Molecular and cellular endocrinology (05-05-2010)“…Muscle repair following injury is preceded by a rapid inflammatory response with myoblasts being exposed to high levels of prostaglandin D(2) (PGD(2)) from…”
Get full text
Journal Article -
11
The Role of Eif6 in Skeletal Muscle Homeostasis Revealed by Endurance Training Co-expression Networks
Published in Cell reports (Cambridge) (07-11-2017)“…Regular endurance training improves muscle oxidative capacity and reduces the risk of age-related disorders. Understanding the molecular networks underlying…”
Get full text
Journal Article -
12
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches
Published in Leukemia & lymphoma (01-04-2012)“…Abstract Chronic lymphocytic leukemia (CLL) remains associated with low complete response rates and high relapse rates. This is in part due to poor…”
Get full text
Journal Article -
13
Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance
Published in Haematologica (Roma) (01-11-2010)“…Tumor cells in chronic lymphocytic leukemia accumulate in the periphery through the proliferation of a minority of cells in lymph nodes. The proliferative and…”
Get full text
Journal Article -
14
Prostaglandins in muscle regeneration
Published in Journal of muscle research and cell motility (01-12-2008)“…Muscle regeneration is a tightly orchestrated process where activated satellite cells (myoblasts) respond to external stimuli in order to proliferate,…”
Get full text
Journal Article -
15
Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers
Published in Contemporary clinical trials communications (01-06-2019)“…Abstract We previously reported the safety and efficacy of low dose BaP [ B ezafibrate (Bez) a nd Medroxy p rogesterone acetate (MPA)] in 20 acute myeloid…”
Get full text
Journal Article -
16
Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)
Published in British journal of haematology (01-04-2010)“…Summary Acute myeloid leukaemia (AML) causes life‐threatening deficits of functional blood cells that require management using red cell and platelet…”
Get full text
Journal Article -
17
Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study
Published in The Lancet. Haematology (01-12-2017)“…Multiple myeloma is consistently preceded by monoclonal gammopathy of undetermined significance (MGUS), which is usually only treated by a form of…”
Get full text
Journal Article -
18
Elevated FOSB‐expression; a potential marker of valproate sensitivity in AML
Published in British journal of haematology (01-02-2009)“…Summary Histone deacetylase inhibitors (HDIs) are emerging as valuable new agents in the treatment of acute myeloid leukaemia (AML). However, since response…”
Get full text
Journal Article -
19
-
20